Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.952 |
High Similarity |
NPD3027 |
Phase 3 |
0.9147 |
High Similarity |
NPD1613 |
Approved |
0.9147 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8837 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.876 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.845 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.845 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8268 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8163 |
Intermediate Similarity |
NPD1934 |
Approved |
0.816 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8154 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8145 |
Intermediate Similarity |
NPD228 |
Approved |
0.8049 |
Intermediate Similarity |
NPD2684 |
Approved |
0.8027 |
Intermediate Similarity |
NPD4678 |
Approved |
0.8027 |
Intermediate Similarity |
NPD4675 |
Approved |
0.8015 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7926 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7895 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7883 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7879 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7871 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD290 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.781 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.78 |
Intermediate Similarity |
NPD37 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7763 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7763 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7763 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7754 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7708 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7705 |
Intermediate Similarity |
NPD291 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7676 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7673 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7673 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7643 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7634 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.761 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD2677 |
Approved |
0.76 |
Intermediate Similarity |
NPD968 |
Approved |
0.76 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7594 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7571 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7559 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7559 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7556 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7533 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD6671 |
Approved |
0.748 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7465 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7465 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7434 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7423 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5772 |
Approved |
0.74 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7383 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7383 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7343 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD2978 |
Approved |
0.729 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7285 |
Intermediate Similarity |
NPD52 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD2796 |
Approved |
0.726 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7252 |
Intermediate Similarity |
NPD821 |
Approved |
0.7252 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7248 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7192 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7185 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD556 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD940 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7143 |
Intermediate Similarity |
NPD846 |
Approved |
0.7143
|
Intermediate Similarity |
NPD6099 |
Approved |